We are live on ! Find out more
MRSN

Mersana Therapeutics

Delisted

MRSN was delisted on the 5th of January, 2026.

128 hedge funds and large institutions have $322M invested in Mersana Therapeutics in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 49 increasing their positions, 37 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 15

32% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 37

5% more funds holding

Funds holding: 122128 (+6)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.03% less ownership

Funds ownership: 3.9%3.88% (-0.03%)

26% less capital invested

Capital invested by funds: $436M → $322M (-$114M)

89% less call options, than puts

Call options by funds: $42K | Put options by funds: $372K

Holders
128
Holders Change
+6
Holders Change %
+4.92%
% of All Funds
2.02%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
21
Increased
49
Reduced
37
Closed
15
Calls
$42K
Puts
$372K
Net Calls
-$330K
Net Calls Change
+$608K